SERAXIS Trademark

Trademark Overview

On Wednesday, October 20, 2021, a trademark application was filed for SERAXIS with the United States Patent and Trademark Office. The USPTO has given the SERAXIS trademark a serial number of 97083181. The federal status of this trademark filing is REGISTERED as of Tuesday, January 17, 2023. This trademark is owned by Seraxis Inc. The SERAXIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
seraxis

General Information

Serial Number97083181
Word MarkSERAXIS
Filing DateWednesday, October 20, 2021
Status700 - REGISTERED
Status DateTuesday, January 17, 2023
Registration Number6959010
Registration DateTuesday, January 17, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2022

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 5, 2021
Primary Code042
First Use Anywhere DateFriday, March 15, 2013
First Use In Commerce DateFriday, March 15, 2013

Trademark Owner History

Party NameSeraxis Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGermantown, MD 20874
Party NameSeraxis Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGermantown, MD 20874
Party NameSeraxis Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGermantown, MD 20874

Trademark Events

Event DateEvent Description
Tuesday, January 17, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 17, 2023REGISTERED-PRINCIPAL REGISTER
Friday, December 16, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 15, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 21, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 1, 2022USE AMENDMENT FILED
Monday, November 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 1, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, October 25, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 30, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 27, 2022ASSIGNED TO EXAMINER
Thursday, April 21, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 21, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 23, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords

seraxis fields biotechnology pharmaceutical development research